These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Acute, subchronic and chronic toxicity of the new angiotensin converting enzyme inhibitor ramipril. Donaubauer HH, Mayer D. Arzneimittelforschung; 1988 Jan; 38(1):14-20. PubMed ID: 2966628 [Abstract] [Full Text] [Related]
14. Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat. Caspritz G, Alpermann HG, Schleyerbach R. Arzneimittelforschung; 1986 Nov; 36(11):1605-8. PubMed ID: 3028436 [Abstract] [Full Text] [Related]
16. General pharmacology of ramipril. Omosu M, Komine I, Becker RH, Schölkens BA. Arzneimittelforschung; 1988 Sep; 38(9):1309-17. PubMed ID: 2975947 [Abstract] [Full Text] [Related]
17. Effect of peptidase inhibitors on [Met5]enkephalin-Arg6-Phe7 and [Met5]enkephalin-Arg6-Gly7-Leu8-induced antinociception. Mellstrom B, Iadarola MJ, Costa E. Eur J Pharmacol; 1987 Jan 13; 133(2):185-90. PubMed ID: 2949992 [Abstract] [Full Text] [Related]
18. Effects of the novel compound, Hoe 065, upon impaired learning and memory in rodents. Hock FJ, Gerhards HJ, Wiemer G, Stechl J, Rüger W, Urbach H. Eur J Pharmacol; 1989 Nov 14; 171(1):79-85. PubMed ID: 2612569 [Abstract] [Full Text] [Related]